Literature DB >> 8641558

The fibronectin gene as a model for splicing and transcription studies.

A R Kornblihtt1, C G Pesce, C R Alonso, P Cramer, A Srebrow, S Werbajh, A F Muro.   

Abstract

The fibronectin (FN) gene has become paradigmatic to illustrate genome evolution by exon shuffling, generation of protein diversity by alternative mRNA splicing, and topological coordination between transcription and splicing. Alternative splicing in three sites of the primary transcript gives rise to multiple FN polypeptides. This process is cell type-, development- and age-regulated. The different FN variants seem to play specific roles in FN dimer secretion, blood clotting, adhesion to lymphoid cells, skin wound healing, atherosclerosis, and liver fibrosis. This review focuses on function assignment to the alternatively spliced segments, as well as on the external signals and cis-acting sequences that control the mechanisms of alternative splicing. We also discuss FN transcriptional regulation in response to viral transformation, growth factors, and cyclic AMP in the light of promoter architecture and its interaction with specific transcription factors. The relevance of FN RNA "tracks" as assembly lines of coordinated transcription and RNA processing is also addressed.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8641558     DOI: 10.1096/fasebj.10.2.8641558

Source DB:  PubMed          Journal:  FASEB J        ISSN: 0892-6638            Impact factor:   5.191


  49 in total

1.  EDA-containing cellular fibronectin induces fibroblast differentiation through binding to alpha4beta7 integrin receptor and MAPK/Erk 1/2-dependent signaling.

Authors:  Martin Kohan; Andres F Muro; Eric S White; Neville Berkman
Journal:  FASEB J       Date:  2010-07-19       Impact factor: 5.191

2.  Loss of EDB+ fibronectin isoform is associated with differentiation of alveolar epithelial cells in human fetal lung.

Authors:  H Arai; H Hirano; S Mushiake; M Nakayama; G Takada; K Sekiguchi
Journal:  Am J Pathol       Date:  1997-08       Impact factor: 4.307

3.  Regulation of fibronectin splicing in sinusoidal endothelial cells from normal or injured liver.

Authors:  Ming-Ling Chang; Jeng-Chang Chen; Claudio R Alonso; Alberto R Kornblihtt; D Montgomery Bissell
Journal:  Proc Natl Acad Sci U S A       Date:  2004-12-16       Impact factor: 11.205

4.  Mislocalized scaffolding by the Na-H exchanger NHE1 dominantly inhibits fibronectin production and TGF-beta activation.

Authors:  Anastasios Karydis; Maite Jimenez-Vidal; Sheryl P Denker; Diane L Barber
Journal:  Mol Biol Cell       Date:  2009-02-18       Impact factor: 4.138

5.  Co-transcriptional splicing of constitutive and alternative exons.

Authors:  Amy Pandya-Jones; Douglas L Black
Journal:  RNA       Date:  2009-08-05       Impact factor: 4.942

6.  Alternative splicing of the fibronectin EIIIB exon depends on specific TGCATG repeats.

Authors:  L P Lim; P A Sharp
Journal:  Mol Cell Biol       Date:  1998-07       Impact factor: 4.272

7.  Functional association between promoter structure and transcript alternative splicing.

Authors:  P Cramer; C G Pesce; F E Baralle; A R Kornblihtt
Journal:  Proc Natl Acad Sci U S A       Date:  1997-10-14       Impact factor: 11.205

Review 8.  The myofibroblast matrix: implications for tissue repair and fibrosis.

Authors:  Franco Klingberg; Boris Hinz; Eric S White
Journal:  J Pathol       Date:  2013-01       Impact factor: 7.996

9.  Highly multiplexed subcellular RNA sequencing in situ.

Authors:  Je Hyuk Lee; Evan R Daugharthy; Jonathan Scheiman; Reza Kalhor; Joyce L Yang; Thomas C Ferrante; Richard Terry; Sauveur S F Jeanty; Chao Li; Ryoji Amamoto; Derek T Peters; Brian M Turczyk; Adam H Marblestone; Samuel A Inverso; Amy Bernard; Prashant Mali; Xavier Rios; John Aach; George M Church
Journal:  Science       Date:  2014-02-27       Impact factor: 47.728

10.  Polarized fibronectin secretion induced by adenosine regulates bacterial-epithelial interaction in human intestinal epithelial cells.

Authors:  Baljit Walia; Florencia E Castaneda; Lixin Wang; Vasantha L Kolachala; Rahul Bajaj; Jesse Roman; Didier Merlin; Andrew T Gewirtz; Shanthi V Sitaraman
Journal:  Biochem J       Date:  2004-09-01       Impact factor: 3.857

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.